Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)

Clinical trial NCT07002398 · RECRUITING

Trial details

NCT number: NCT07002398
Sponsor: VeonGen Therapeutics GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Retinal Dystrophy Due to Biallelic ABCA4 Mutations Stargardt Disease 1

Start date: 2024-12-23
Primary completion: 2026-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.